Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has another enormous opportunity that's getting very little attention.
An experimental drug called amycretin showed signs it could be more potent than Eli Lilly’s rival Zepbound, though analysts ...
Berenberg Bank analyst Kerry Holford maintained a Hold rating on Hochschild Mining (HOC – Research Report) yesterday and set a price target of ...
The CEO of Germany's Merck KGaA said a recovery in sales growth at its existing business means it can take a cautious ...
3d
In a report released yesterday, Akash Tewari from Jefferies maintained a Buy rating on Eli Lilly & Co (LLY – Research Report), with a price ...
Alzheimer's disease Therapeutics Market. LAS VEGAS, NV, UNITED STATES, January 23, 2025 /EINPresswire / -- DelveInsight's“Acute Respiratory Distress Synd ...
The market for GLP-1 drugs is projected to exceed $200 billion in annual sales by 2031, according to Morningstar Equity ...
DelveInsight's Heart failure with Reduced Ejection Fraction Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM.
Patent law specialist Hoffmann Eitle is taking over the Dusseldorf office of boutique KSVR (König - Szynka - Tilmann - von Renesse) next month. KSVR partners Gregor König, Dorothea von Renesse and ...
In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... This time around, he likened China to ...
Compared with the same month last year, the European Union imported significantly more pharmaceutical products from Russia in ...
GlobalData analysts are predicting an Alzheimer’s disease market boom, tipping its value across major regions to increase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback